🔎 Trials Near Me

Utama › Nefritis Lupus › New York

Kajian klinikal Nefritis Lupus di New York

16 kajian untuk Nefritis Lupus sedang mencari peserta di lokasi di New York.

Bandar di New York

Teks kajian rasmi (Bahasa Inggeris)

Study of Efficacy and Safety of LNP023 in Participants With Active Lupus Nephritis Class III-IV, +/- V

  • Stony Brook Internists PC, East Setauket
Mengambil pesertaFasa 2
Umur 18 hingga 100 · Semua jantina · Dikemas kini 1 Okt 2026 · NCT05268289

Phase III Extension Study of Efficacy and Safety of Ianalumab With or Without Study Treatment Withdrawal in Participants With Lupus Nephritis (SIRIUS-LN Extension)

  • Circuit Clinical, Orchard Park
Mengambil pesertaFasa 3
Umur 18 hingga 100 · Semua jantina · Dikemas kini 28 Sep 2026 · NCT06711887

A Phase IIa Study of ICG318 CAR-T in Refractory Systemic Lupus Erythematosus With or Without Lupus Nephritis

  • New York Medical College, Hawthorne
  • NorthWell, New Hyde Park
Mengambil pesertaFasa 2
Umur 16 hingga 70 · Semua jantina · Dikemas kini 17 Sep 2026 · NCT07328581

VIBRANT: VIB4920 for Active Lupus Nephritis

  • Feinstein Institute for Medical Research: Center for Autoimmune and Musculoskeletal Diseases, Manhasset
  • Hospital for Special Surgery, New York: Division of Rheumatology, New York
  • Columbia University Medical Center: Department of Medicine, Division of Rheumatology, New York
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 16 Sep 2026 · NCT05201469

The Pediatric Lupus Nephritis Mycophenolate Mofetil (PLUMM) Study

  • Hospital for Special Surgery, New York
  • Children's Hospital at Montefiore, New York
Mengambil pesertaFasa 2
Umur 8 hingga 20 · Semua jantina · Dikemas kini 14 Sep 2026 · NCT05538208

A Study to Investigate the Safety, Tolerability, and Efficacy of AZD0120 in Adults With Refractory SLE

  • Research Site, New York
  • Research Site, Syracuse
Mengambil pesertaFasa 1/2
Umur 18 hingga 70 · Semua jantina · Dikemas kini 10 Sep 2026 · NCT06897930

A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease

  • Icahn School of Medicine at Mount Sinai, New York
Mengambil pesertaFasa 1
Umur 18 hingga 74 · Semua jantina · Dikemas kini 10 Sep 2026 · NCT07085104

A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Obinutuzumab in Adolescents With Active Class III or IV Lupus Nephritis and the Safety and PK of Obinutuzumab in Pediatric Participants

  • Cohen Children's Medical Center of New York, Queens
Mengambil pesertaFasa 2
Umur 5 hingga 17 · Semua jantina · Dikemas kini 3 Sep 2026 · NCT05039619

RESET-SLE: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Systemic Lupus Erythematosus

  • University of Rochester, Rochester
Mengambil pesertaFasa 1/2
Umur 18 hingga 65 · Semua jantina · Dikemas kini 26 Ogo 2026 · NCT06121297

Obe-cel in Severe, Refractory Systemic Lupus Erythematosus (SLE) With Active Lupus Nephritis (LN)

  • Icahn School of Medicine at Mount Sinai, New York
  • State University of New York Upstate Medical Center (SUNY), Syracuse
Mengambil pesertaFasa 2
Umur 12 hingga 65 · Semua jantina · Dikemas kini 24 Ogo 2026 · NCT07053800

PRESERVE: LUPKYNIS in Combination With Belimumab, Obinutuzumab or Anifrolumab in Patients With Lupus Nephritis

  • Buffalo Rheumatology and Medicine, PLLC, Orchard Park
Mengambil pesertaFasa 4
Umur 18 hingga 75 · Semua jantina · Dikemas kini 3 Ogo 2026 · NCT07611214

A Phase 1/2 Study of NKX019 in Subjects With Autoimmune Disease (Ntrust-1)

  • Nkarta Investigational Site, New York
  • Nkarta Investigational Site, Stony Brook
  • Nkarta Investigational Site, Syracuse
Mengambil pesertaFasa 1/2
Umur 18 hingga 75 · Semua jantina · Dikemas kini 4 Jun 2026 · NCT06557265

A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease

  • Montefiore Medical Center, New York
Mengambil pesertaFasa 1
Umur 12 hingga 70 · Semua jantina · Dikemas kini 22 Mei 2026 · NCT06308978

Lupus Landmark Study: A Prospective Registry and Biorepository

  • The Feinstein Institutes for Medical Research, Manhasset
  • Columbia University Medical Center, New York
  • Northwell Health, New York
  • dan 1 lagi
Mengambil pesertaKajian pemerhatian
Umur 18 hingga 110 · Semua jantina · Dikemas kini 15 Apr 2026 · NCT05934149

Safety and Efficacy of ONT01 in Lupus

  • Hospital for Special Surgery, New York
Mengambil pesertaFasa awal 1
Umur 18 ke atas · Semua jantina · Dikemas kini 20 Nov 2025 · NCT07107659

Repository of Novel Analytes Leading to Autoimmune, Inflammatory and Diabetic Nephropathies (RENAL AID)

  • The Rogosin Institute, New York
Mengambil pesertaKajian pemerhatian
Umur 18 ke atas · Semua jantina · Dikemas kini 4 Apr 2025 · NCT01802034

Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.